Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001062993-23-014999

Options or other derivatives

  • Director acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kavuru Vimal Director 2023-07-14 Grant or award · Stock Options (Right to Buy) +12,500 12,500 D: show line 1 in the form
Loading xslF345X05/form4.xml…